Sanofi Pasteur S.A.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
12
Ending by 2030
Mar 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 30, 2026The maintenance fee for Method of Storing a Vaccine Containing an Aluminum Adjuvant (US 9,066,895) comes due Dec 30, 2026. Unpaid by Jun 30, 2027, it lapses early.
- 1 fee due Mar 29, 2027The maintenance fee for Process for Culturing Adherent Cells (US 9,145,543) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
- 1 fee due Apr 22, 2027The maintenance fee for Heating Device for Rotary Drum Freeze-Dryer (US 10,451,345) comes due Apr 22, 2027. Unpaid by Oct 22, 2027, it lapses early.
- 2 fees due Jul 7 to 14, 2027 · next Jul 7
- 1 fee due Sep 29, 2027The maintenance fee for Process For Stabilizing An Adjuvant Containing Vaccine Composition (US 9,295,721) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,420,805 | Process For Preparing Prophyrin Derivatives, Such As Protoprophyrin (IX) And Synthesis Intermediates In force · High confidence | In force | High confidence | |
| US 9,295,721 | Process For Stabilizing An Adjuvant Containing Vaccine Composition In force · High confidence | In force | High confidence | |
| US 9,878,028 | Process For Stabilizing An Adjuvant Containing Vaccine Composition In force · High confidence | In force | High confidence | |
| US 8,026,358 | Process for Preparing Porphyrin Derivatives, Such as Protoporphyrin (IX) and Synthesis Intermediates In force · High confidence | In force | High confidence | |
| US 8,016,120 | Method for Purifying a Viral Suspension In force · High confidence | In force | High confidence | |
| US 8,703,095 | Immuno-adjuvant emulsion In force · High confidence | In force | High confidence | |
| US 9,504,659 | Thermoreversible Oil-In-Water Emulsion In force · High confidence | In force | High confidence | |
| US 9,750,800 | Method for Purifying the Rabies Virus In force · High confidence | In force | High confidence | |
| US 8,551,527 | Process for Stabilizing an Adjuvant Containing Vaccine Composition In force · High confidence | In force | High confidence | |
| US 8,673,617 | Culture Medium for Haemophilus Influenzae Type B In force · High confidence | In force | High confidence |
Also on record, not counted in the 26: 2 patents in force now held by others · 18 lapsed for an unpaid fee · 2 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
9 abandoned · 2 no status recorded